歼击机飞行员鼻咽癌放疗后复飞1例

Re-flight of fi ghter pilots with nasopharyngeal carcinoma after radiotherapy

目的通过典型案例探讨飞行人员鼻咽癌放化疗后的复飞问题。方法回顾分析1例歼击机飞行员患鼻咽癌后的临床诊治、随访和复飞经历,提出我国的鼻咽癌航空医学鉴定原则。结果本例飞行员鼻咽癌放化疗后8个月鼻咽癌消失,无严重并发症,低压舱前后咽鼓管功能、听觉功能和前庭功能等飞行相关检查均正常,给予双座飞行合格结论。出院后飞行53 h,空中生活适应良好。放疗后12个月飞行相关检查均正常,取消双座限制,单座飞行147 h,空中生活适应良好。放疗后20个月飞行相关检查均正常,继续单座飞行。结论若飞行人员早期鼻咽癌放化疗后效果好,且无严重放疗并发症、无肿瘤复发和转移,咽鼓管功能、听功能和前庭功能等航空医学检查正常,可以考虑特许飞行合格。

Objective To study the re-flight of fighter pilots with nasopharyngeal carcinoma after radiotherapy. Methods Clinical data about a pilot with nasopharyngeal carcinoma （including diagnosis and treatment of nasopharyngeal carcinoma, follow-up and re-flight of the pilot） were retrospectively analyzed in order to establish its medical identification principles. Results The nasopharyngeal carcinoma disappeared in the pilot 8 months after radiotherapy without severe complications. Hypobaric chamber test showed that his eustachian tube, auditory and vestibular functions were normal. The fighter pilot was considered to be qualified to fly the double-seat fighter who adapted well to the flying for about 53 h. Flight-related tests showed that he could fly the single- seat fighter 20 months after radiotherapy. Conclusion The efficiency of radiotherapy is good for early nasopharyngeal carcinoma in pilots with no severe complications, no recurrence and metastasis. Fighter pilots can be allowed to fly when fight-related tests show that their eustachian tube, auditory and vestibular functions are normal.